Chemoinformaics analysis of 3-Butyl-5-methyldihydro-2(3H)-furanone
| Molecular Weight | 156.225 | nRot | 3 |
| Heavy Atom Molecular Weight | 140.097 | nRig | 6 |
| Exact Molecular Weight | 156.115 | nRing | 1 |
| Solubility: LogS | -2.745 | nHRing | 1 |
| Solubility: LogP | 2.782 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 27.3027 |
| nHD | 0 | BPOL | 18.6553 |
| QED | 0.585 |
| Synth | 3.24 |
| Natural Product Likeliness | 1.848 |
| NR-PPAR-gamma | 0.189 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.005 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -4.43 |
| MDCK | 0.0000316 |
| BBB | 0.995 |
| PPB | 0.58987 |
| VDSS | 1.05 |
| FU | 0.461005 |
| CYP1A2-inh | 0.536 |
| CYP1A2-sub | 0.46 |
| CYP2c19-inh | 0.158 |
| CYP2c19-sub | 0.79 |
| CYP2c9-inh | 0.081 |
| CYP2c9-sub | 0.836 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.327 |
| CYP3a4-inh | 0.123 |
| CYP3a4-sub | 0.265 |
| CL | 9.566 |
| T12 | 0.374 |
| hERG | 0.016 |
| Ames | 0.028 |
| ROA | 0.029 |
| SkinSen | 0.929 |
| Carcinogencity | 0.637 |
| EI | 0.983 |
| Respiratory | 0.604 |
| NR-Aromatase | 0.013 |
| Antiviral | No |
| Prediction | 0.939437 |